Jensyn Cone Sullivan

Faculty, Staff and Student Publications Publication Date 2-26-2026 Journal Transfusion Medicine Reviews DOI 10.1016/j.tmrv.2026.150979 Abstract Primary thrombocytosis is associated with increased risk of thromboembolism and bleeding. Therapeutic plateletpheresis (TPP), capable of rapid, transient platelet (Plt) count reduction, is employed as an emergency intervention for symptomatic thrombocytosis while awaiting the therapeutic effect of medical cytoreductive therapy.

Corresponding Author Ronald George Hauser III VA Connecticut Healthcare System, West Haven, Connecticut, USA Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut, USA Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA Correspondence Ronald George Hauser III, VA Connecticut Healthcare System, West Haven, CT, USA. Email: [email protected] Search for more papers by this author

CONFLICT OF INTEREST STATEMENT Ronald G. Hauser is on the board of the Transfusion Antibody Exchange, Inc. for which he does not receive any financial compensation. All other authors declare no competing interests. Generative AI systems (LLMs) were study interventions. No generative AI was used to draft, revise, or edit the manuscript text, and all results were verified by the authors.